Latest News

Prism Health North Texas HIV AIDS Clinical Research Team

New Single Tablet Regiment Supported by Clinical Research Team

DALLAS, TX (Feb. 9, 2018) – Wednesday, the Food and Drug Administration announced their approval of Biktarvy®.  Biktarvy® is a combination of Descovy® + Bictegravir – a new single tablet

InMind: Clinical Research Spotlight

The InMind study is evaluating treatment interventions for HIV-associated neurocognitive disorders (HAND).   HAND is a broad term that describes problems related to thinking, memory, mood and physical coordination/function.   Very often

How's Your Heart?

February is heart month. February is the month set aside to care for and reconnect with our heart – from celebrating the love in our lives during Valentine’s Day to

Mission Statement

Advancing the health of North Texas through education, research, prevention, and personalized integrated HIV care.

Facebook

Facebook By Weblizar Powered By Weblizar

Health, Hope and Recovery

A program for HIV positive individuals who are homeless or unstably housed and who have mental health and/or substance abuse disorders.

More Videos